These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21863741)

  • 1. [Mitochondrial disfunction in Parkinson's disease].
    Buneeva OA; Medvedev AE
    Biomed Khim; 2011; 57(3):246-81. PubMed ID: 21863741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in Parkinson's disease.
    Winklhofer KF; Haass C
    Biochim Biophys Acta; 2010 Jan; 1802(1):29-44. PubMed ID: 19733240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial-Associated Membranes in Parkinson's Disease.
    Hattori N; Arano T; Hatano T; Mori A; Imai Y
    Adv Exp Med Biol; 2017; 997():157-169. PubMed ID: 28815529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.
    Area-Gomez E; Guardia-Laguarta C; Schon EA; Przedborski S
    J Clin Invest; 2019 Jan; 129(1):34-45. PubMed ID: 30601141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.
    Swerdlow RH
    Antioxid Redox Signal; 2012 May; 16(9):950-64. PubMed ID: 21338319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PINK1 in mitochondrial function.
    Plun-Favreau H; Hardy J
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11041-2. PubMed ID: 18687903
    [No Abstract]   [Full Text] [Related]  

  • 10. Damage in Mitochondrial DNA Associated with Parkinson's Disease.
    Martín-Jiménez R; Lurette O; Hebert-Chatelain E
    DNA Cell Biol; 2020 Aug; 39(8):1421-1430. PubMed ID: 32397749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease.
    Langley MR; Ghaisas S; Palanisamy BN; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Exp Neurol; 2021 Jul; 341():113716. PubMed ID: 33839143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in Parkinson's disease.
    Schapira AH
    Cell Death Differ; 2007 Jul; 14(7):1261-6. PubMed ID: 17464321
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
    Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
    Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights on the mitochondrial proteome plasticity in Parkinson's disease.
    Aroso M; Ferreira R; Freitas A; Vitorino R; Gomez-Lazaro M
    Proteomics Clin Appl; 2016 Apr; 10(4):416-29. PubMed ID: 26749507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a pathogenic role for mitochondria in Parkinson's disease?
    Vives-Bauza C; de Vries RL; Tocilescu MA; Przedborski S
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S241-4. PubMed ID: 20083000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in idiopathic Parkinson disease.
    Parker WD; Swerdlow RH
    Am J Hum Genet; 1998 Apr; 62(4):758-62. PubMed ID: 9529370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the mitochondrial NCX in the mechanism of neurodegeneration in Parkinson's disease.
    Wood-Kaczmar A; Deas E; Wood NW; Abramov AY
    Adv Exp Med Biol; 2013; 961():241-9. PubMed ID: 23224884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease.
    Shi G; Lee JR; Grimes DA; Racacho L; Ye D; Yang H; Ross OA; Farrer M; McQuibban GA; Bulman DE
    Hum Mol Genet; 2011 May; 20(10):1966-74. PubMed ID: 21355049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond Deubiquitylation: USP30-Mediated Regulation of Mitochondrial Homeostasis.
    Hou J; Eldeeb M; Wang X
    Adv Exp Med Biol; 2017; 1038():133-148. PubMed ID: 29178074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.